{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:09:23Z","timestamp":1760058563097,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III (ISCIII)","award":["PI19\/01569"],"award-info":[{"award-number":["PI19\/01569"]}]},{"DOI":"10.13039\/501100004587","name":"European Union","doi-asserted-by":"publisher","award":["PI19\/01569"],"award-info":[{"award-number":["PI19\/01569"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Foundation for Biosanitary Research and Innovation in Primary Care (FIIBAP)","award":["PI19\/01569"],"award-info":[{"award-number":["PI19\/01569"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: The current study aims to estimate the frequency of abnormal renal status (ARS, defined as chronic kidney disease (CKD) diagnosis in electronic medical records or current albuminuria) in people with newly diagnosed diabetes mellitus (DM), to determine the associated risk factors, and to evaluate the level of compliance with good clinical practice recommendations. Methods: Cross-sectional study with 1030 adults diagnosed with DM in the last 4 years. Anthropometric, clinical, analytical, and lifestyle variables were collected. Multivariate analyses were performed to determine the factors associated with ARS. Results: Hypercholesterolaemia, metabolic syndrome, hypertension, obesity, hypertriglyceridaemia, and cardiovascular disease (CVD) were the most prevalent comorbidities. ARS was present in 11.5% of patients. The variables associated with ARS were male sex (OR: 1.78; 95% CI, 1.16\u20132.75), age \u226570 years (OR: 2.96; 95% CI: 1.92\u20134.56), hypertension (OR: 1.59; 95% CI: 1.03\u20132.44), CVD (OR: 1.73; 95% CI: 1.03\u20132.90), and hemoglobin A1c (HbA1c) \u22658% (OR: 2.26; 95% CI, 1.19\u20134.27). Among patients with hypertension and albuminuria, 80% received angiotensin-converting enzyme inhibitors (ACE inhibitor) or an angiotensin receptor blocker (ARB), compared to 60% of those with albuminuria without hypertension. The 42.4% patients with ARS were treated with sodium-glucose cotransporter type 2 inhibitors (SGLT2i) and 72% with statins, but only 31.5% achieved the target low density lipoproteins cholesterol (LDLc) &lt; 70 mg\/dL. Conclusions: ARS in newly diagnosed patients with DM is less common than described in the literature, but risk factors for its development are highly prevalent. Adherence to good clinical practice recommendations was poor, especially in LDL cholesterol targets and the use of SGLT2i.<\/jats:p>","DOI":"10.3390\/jcm14082732","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:09:17Z","timestamp":1744790957000},"page":"2732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal Status in Newly Diagnosed Patients with Diabetes Mellitus: A Descriptive Study in Primary Care and Opportunities for Improving Management"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6702-909X","authenticated-orcid":false,"given":"Pilar","family":"Vich-P\u00e9rez","sequence":"first","affiliation":[{"name":"Hospital La Paz Institute for Health Research (IdiPAZ), 28029 Madrid, Spain"},{"name":"Los Alpes Health Centre, 28022 Madrid, Spain"},{"name":"Foundation for Biosanitary Research and Innovation in Primary Care, 28003 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Taulero-Escalera","sequence":"additional","affiliation":[{"name":"Foundation for Biosanitary Research and Innovation in Primary Care, 28003 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Regueiro-Toribio","sequence":"additional","affiliation":[{"name":"Mar B\u00e1ltico Health Centre, 28033 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"C\u00e1rdenas-de Miguel","sequence":"additional","affiliation":[{"name":"Los Alpes Health Centre, 28022 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"San Rom\u00e1n Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Los Alpes Health Centre, 28022 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Salinero-Fort","sequence":"additional","affiliation":[{"name":"Hospital La Paz Institute for Health Research (IdiPAZ), 28029 Madrid, Spain"},{"name":"Foundation for Biosanitary Research and Innovation in Primary Care, 28003 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the LADA-PC Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.2337\/dc23-S011","article-title":"11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group (2022). KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int., 102, S1\u2013S127.","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The global burden of chronic kidney disease","volume":"395","author":"Cockwell","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D.R. (2016). Global Prevalence of Chronic Kidney Disease\u2014A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bellasi, A., Di Lullo, L., and Di Iorio, B. (2019). Chronic Kidney Disease: The Silent Epidemy. J. Clin. Med., 8.","DOI":"10.3390\/jcm8111795"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Vich-P\u00e9rez, P., Ab\u00e1nades-Herranz, J.C., Mora-Navarro, G., Carrasco-Sayalero, \u00c1.M., Salinero-Fort, M.\u00c1., Sevilla-Machuca, I., Sanz-Pascual, M., \u00c1lvarez Hern\u00e1ndez-Ca\u00f1izares, C., and de Burgos-Lunar, C. (2023). LADA-PC Research Consortium Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0281657"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee 2 (2022). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care, 45, S17\u2013S38.","DOI":"10.2337\/dc22-S002"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"(2002). National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e068938","DOI":"10.1136\/bmjopen-2022-068938","article-title":"Validation of diagnosis of acute myocardial infarction and stroke in electronic medical records: A primary care cross-sectional study in Madrid, Spain (the e-MADVEVA Study)","volume":"13","year":"2023","journal-title":"BMJ Open"},{"key":"ref_13","first-page":"175","article-title":"Basic guidelines for detecting sedentarism and recommendations for physical activity in primary care","volume":"47","year":"2015","journal-title":"Aten. Primaria"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3945\/jn.110.135566","article-title":"A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women","volume":"141","author":"Estruch","year":"2011","journal-title":"J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L., and Caughey, G.E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatr., 17.","DOI":"10.1186\/s12877-017-0621-2"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jdiacomp.2015.04.007","article-title":"Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011","volume":"29","author":"Schroeder","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gatwood, J., Chisholm-Burns, M., Davis, R., Thomas, F., Potukuchi, P., Hung, A., and Kovesdy, C.P. (2018). Evidence of chronic kidney disease in veterans with incident diabetes mellitus. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192712"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21501319241259325","DOI":"10.1177\/21501319241259325","article-title":"Prevalence of Chronic Kidney Disease in Individuals With Type 2 Diabetes Within Primary Care: A Cross-Sectional Study","volume":"15","year":"2024","journal-title":"J. Prim. Care Community Health"},{"key":"ref_19","first-page":"552","article-title":"Grupo de Investigaci\u00f3n ERC Arag\u00f3n [Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care]","volume":"30","year":"2010","journal-title":"Nefrol. Publ. Off. Soc. Espanola Nefrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","article-title":"Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes","volume":"5","author":"Plantinga","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Salinero-Fort, M.A., San Andr\u00e9s-Rebollo, F.J., de Burgos-Lunar, C., G\u00f3mez-Campelo, P., Chico-Moraleja, R.M., L\u00f3pez de Andr\u00e9s, A., Jim\u00e9nez-Garc\u00eda, R., and MADIABETES Group (2015). Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: The MADIABETES Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122030"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"Khunti","year":"2022","journal-title":"Kidney Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2024.27402","article-title":"Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis","volume":"333","author":"Hanlon","year":"2025","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2142078","DOI":"10.1001\/jamanetworkopen.2021.42078","article-title":"Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis","volume":"5","author":"Bhattarai","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.15277\/bjd.2021.292","article-title":"A systematic review and meta-analysis of the impact of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiovascular outcomes in biologically healthy older adults","volume":"21","author":"Strain","year":"2021","journal-title":"Br. J. Diabetes"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications (DCCT) Research Group (1995). Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int., 47, 1703\u20131720.","DOI":"10.1038\/ki.1995.236"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998). UK Prospective Diabetes Study (UKPDS) Group. Lancet Lond. Engl., 352, 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Aregawi, K., Kabew Mekonnen, G., Belete, R., and Kucha, W. (2024). Prevalence of chronic kidney disease and associated factors among adult diabetic patients: A hospital-based cross-sectional study. Front. Epidemiol., 4.","DOI":"10.3389\/fepid.2024.1467911"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Aminnejad, N., Greiver, M., and Huang, H. (2025). Predicting the onset of chronic kidney disease (CKD) for diabetic patients with aggregated longitudinal EMR data. PLOS Digit. Health, 4.","DOI":"10.1371\/journal.pdig.0000700"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13098-023-01202-x","article-title":"Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis","volume":"15","author":"Fenta","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8890331","DOI":"10.1155\/2020\/8890331","article-title":"Chronic Kidney Disease among Diabetes Patients in Ethiopia: A Systematic Review and Meta-Analysis","volume":"2020","author":"Shiferaw","year":"2020","journal-title":"Int. J. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/dme.12478","article-title":"The influence of sex on renal function decline in people with Type 2 diabetes","volume":"31","author":"Ragot","year":"2014","journal-title":"Diabet. Med. J. Br. Diabet. Assoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/bmj.314.7083.783","article-title":"Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study","volume":"314","author":"Gall","year":"1997","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4626382","DOI":"10.1155\/2016\/4626382","article-title":"Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes","volume":"2016","author":"Kajiwara","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","article-title":"The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study","volume":"63","author":"Keane","year":"2003","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Li, X., Wang, Q., Wu, F., Ye, Z., and Li, Y. (2024). Association between advanced lung cancer inflammation index and chronic kidney disease: A cross-sectional study. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1430471"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hanaoka, H., Aoki, T., Kosaka, T., Yoshinaga, S., Shibata, A., Sakai, R., Kurasawa, T., and Amano, K. (2025). Chronic kidney disease and inflammatory cytokines in rheumatoid arthritis: A potential pathogenic link. Immunol. Med., 1\u201310.","DOI":"10.1080\/25785826.2025.2460267"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kibirige, D., Sekitoleko, I., and Lumu, W. (2023). Burden and predictors of diabetic kidney disease in an adult Ugandan population with new-onset diabetes. BMC Res. Notes, 16.","DOI":"10.1186\/s13104-023-06500-1"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kalyesubula, R., Nankabirwa, J.I., Ssinabulya, I., Siddharthan, T., Kayima, J., Nakibuuka, J., Salata, R.A., Mondo, C., Kamya, M.R., and Hricik, D. (2017). Kidney disease in Uganda: A community based study. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0521-x"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1681\/ASN.2005060638","article-title":"Obesity and risk for chronic renal failure","volume":"17","author":"Ejerblad","year":"2006","journal-title":"J. Am. Soc. Nephrol. JASN"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/8\/2732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:15:37Z","timestamp":1760030137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/8\/2732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jcm14082732"],"URL":"https:\/\/doi.org\/10.3390\/jcm14082732","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}